HomeNewscoronavirusCOVID-19 update | Cumulative doses given in India crosses 170 crore on February 7

COVID-19 update | Cumulative doses given in India crosses 170 crore on February 7

More than 1.52 crore (1,52,95,149) precaution doses have been administered to healthcare workers, frontline workers and those aged 60 and above with comorbidities.

February 07, 2022 / 21:06 IST
Source: AP

The cumulative COVID-19 vaccine doses administered in the country crossed 170 crore landmark on Monday, the Union Health Ministry said. Over 50 lakh (50,48,778) vaccine doses were given till 7 pm on Monday.

More than 1.52 crore (1,52,95,149) precaution doses have been administered to healthcare workers, frontline workers and those aged 60 and above with comorbidities. The daily vaccination tally is expected to increase with the compilation of final reports for the day by late night.

ALSO READ: India reports under 1 lakh COVID-19 cases first time in 31 days

The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started from February 2 last year. The next phase of COVID-19 vaccination commenced from March 1, 2021 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.

The country launched vaccination for all people aged more than 45 years from April 1, 2021. The government then decided to expand its vaccination drive by allowing everyone above 18 to be vaccinated from May 1 last year.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The next phase of COVID-19 vaccination commenced from January 3 this year for adolescents in the age group of 15-18 years. India began administering precaution dose of COVID-19 vaccine to healthcare workers, frontline workers, including personnel deployed for election duty and those aged 60 and above with comorbidities from January 10 amid the country witnessing a spike in coronavirus infections fuelled by omicron variant of the virus.

PTI
first published: Feb 7, 2022 09:06 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347